Home › Funds › Patient Capital Management, LLC › UBS
Patient Capital Management, LLC position in UBS
UBS GROUP AG · Financials
Patient Capital Management, LLC reported holding 704,460 shares of UBS (UBS GROUP AG) in its Q3 2026 13F filing — a position valued at US$33.9M, representing 1.15% of its reported portfolio and ranking #27 among its reported holdings. Patient Capital Management, LLC has disclosed UBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's UBS position evolved
Patient Capital Management, LLC first disclosed a stake in UBS in Q3 2023 at 2,482,612 shares (US$61.2M). The position peaked in Q4 2023 at 2,450,937 shares, worth US$75.7M. Across 13 filings, Patient Capital Management, LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 704,460 shares valued at US$33.9M — a reduction of -249,274 shares quarter over quarter.. Notable position changes include a 26% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.48M | $61.20M | New |
| Q4 2023 | 2.45M | $75.73M | Reduce |
| Q1 2024 | 2.34M | $71.88M | Reduce |
| Q2 2024 | 2.03M | $59.93M | Reduce |
| Q3 2024 | 2.02M | $62.50M | Hold |
| Q4 2024 | 2.04M | $61.93M | Add |
| Q1 2025 | 2.04M | $62.58M | Hold |
| Q2 2025 | 1.94M | $65.53M | Reduce |
| Q3 2025 | 1.50M | $61.53M | Reduce |
| Q4 2025 | 1.19M | $54.99M | Reduce |
| Q1 2026 | 1.24M | $48.52M | Add |
| Q2 2026 | 953.73K | $47.27M | Reduce |
| Q3 2026 | 704.46K | $33.91M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UBS and 13F data
UBS (UBS GROUP AG) is a Financials company. 35 other funds we track also report a position in UBS — the largest reported positions include Norges Bank Investment Management (US$4.75B), Fisher Asset Management, LLC (US$3.07B), Wellington Management Group (US$2.96B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UBS
- Norges Bank Investment Management 95.85M sh · $4.75B · Q2 2026
- Fisher Asset Management, LLC 63.80M sh · $3.07B · Q3 2026
- Wellington Management Group 59.55M sh · $2.96B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 59.55M sh · $2.96B · Q2 2026
- MFS Investment Management 54.10M sh · $2.67B · Q3 2026
- Zurcher Kantonalbank (Zurich Cantonalbank) 51.79M sh · $2.50B · Q3 2026
- Cevian Capital II GP LTD 48.12M sh · $2.38B · Q2 2026
- Pictet Asset Management Holding SA 37.54M sh · $1.81B · Q3 2026
- Dodge & Cox 33.63M sh · $1.67B · Q2 2026
- DODGE & COX 33.63M sh · $1.67B · Q2 2026
- Assenagon Asset Management S.A. 23.72M sh · $1.14B · Q3 2026
- Arrowstreet Capital 17.03M sh · $844.22M · Q2 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held UBS?
Patient Capital Management, LLC has disclosed UBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Patient Capital Management, LLC's current position in UBS?
As of Q3 2026, Patient Capital Management, LLC holds 704.46K shares of UBS (UBS GROUP AG), valued at $33.91M, representing 1.15% of its reported portfolio and ranking #27.
Has Patient Capital Management, LLC been buying or selling UBS?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in UBS. The position peaked in Q4 2023 at 2.45M shares.
Which other funds hold UBS?
Other major institutional holders of UBS include Norges Bank Investment Management, Fisher Asset Management, LLC, Wellington Management Group, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.